BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 37867237)

  • 21. O-GlcNAcylation of histone deacetylases 1 in hepatocellular carcinoma promotes cancer progression.
    Zhu G; Tao T; Zhang D; Liu X; Qiu H; Han L; Xu Z; Xiao Y; Cheng C; Shen A
    Glycobiology; 2016 Aug; 26(8):820-833. PubMed ID: 27060025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Endosome-associated Deubiquitinating Enzyme USP8 Regulates BACE1 Enzyme Ubiquitination and Degradation.
    Yeates EF; Tesco G
    J Biol Chem; 2016 Jul; 291(30):15753-66. PubMed ID: 27302062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ATR-dependent ubiquitin-specific protease 20 phosphorylation confers oxaliplatin and ferroptosis resistance.
    Tang J; Long G; Xiao D; Liu S; Xiao L; Zhou L; Tao Y
    MedComm (2020); 2023 Dec; 4(6):e463. PubMed ID: 38124786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of OGT by Caveolin-1 promotes hepatocellular carcinoma cell migration and invasion.
    Wang L; Feng Y; Zhang C; Chen X; Huang H; Li W; Zhang J; Liu Y
    Cell Biol Int; 2021 Nov; 45(11):2251-2263. PubMed ID: 34288245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ubiquitin-specific protease 5 mediated deubiquitination of LSH links metabolic regulation of ferroptosis to hepatocellular carcinoma progression.
    Yan B; Guo J; Wang Z; Ning J; Wang H; Shu L; Hu K; Chen L; Shi Y; Zhang L; Liu S; Tao Y; Xiao D
    MedComm (2020); 2023 Aug; 4(4):e337. PubMed ID: 37492786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ubiquitin-specific protease USP8 deubiquitinates and stabilizes Cx43.
    Sun J; Hu Q; Peng H; Peng C; Zhou L; Lu J; Huang C
    J Biol Chem; 2018 May; 293(21):8275-8284. PubMed ID: 29626091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA CASC11 suppresses sorafenib-triggered ferroptosis via stabilizing SLC7A11 mRNA in hepatocellular carcinoma cells.
    Chen F; Wang L
    Discov Oncol; 2023 Aug; 14(1):145. PubMed ID: 37552314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. USP8 suppresses death receptor-mediated apoptosis by enhancing FLIP
    Jeong M; Lee EW; Seong D; Seo J; Kim JH; Grootjans S; Kim SY; Vandenabeele P; Song J
    Oncogene; 2017 Jan; 36(4):458-470. PubMed ID: 27321185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. USP8 promotes cancer progression and extracellular vesicle-mediated CD8+ T cell exhaustion by deubiquitinating the TGF-β receptor TβRII.
    Xie F; Zhou X; Li H; Su P; Liu S; Li R; Zou J; Wei X; Pan C; Zhang Z; Zheng M; Liu Z; Meng X; Ovaa H; Ten Dijke P; Zhou F; Zhang L
    EMBO J; 2022 Aug; 41(16):e108791. PubMed ID: 35811497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AMPKα1-mediated ZDHHC8 phosphorylation promotes the palmitoylation of SLC7A11 to facilitate ferroptosis resistance in glioblastoma.
    Wang Z; Wang Y; Shen N; Liu Y; Xu X; Zhu R; Jiang H; Wu X; Wei Y; Tang J
    Cancer Lett; 2024 Mar; 584():216619. PubMed ID: 38211651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. O-GlcNAcylation of RAB10 promotes hepatocellular carcinoma progression.
    Lv Z; Ma G; Zhong Z; Xie X; Li B; Long D
    Carcinogenesis; 2023 Dec; 44(10-11):785-794. PubMed ID: 37218374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromatin-associated OGT promotes the malignant progression of hepatocellular carcinoma by activating ZNF263.
    Wang L; Li G; Zhou Z; Ge C; Chen Q; Liu Y; Zhang N; Zhang K; Niu M; Li W; Zhong X; Wu S; Zhang J; Liu Y
    Oncogene; 2023 Jul; 42(30):2329-2346. PubMed ID: 37353617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. USP8 modulates ubiquitination of LRIG1 for Met degradation.
    Oh YM; Lee SB; Choi J; Suh HY; Shim S; Song YJ; Kim B; Lee JM; Oh SJ; Jeong Y; Cheong KH; Song PH; Kim KA
    Sci Rep; 2014 May; 4():4980. PubMed ID: 24828152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reciprocal cross-regulation between RNF41 and USP8 controls cytokine receptor sorting and processing.
    De Ceuninck L; Wauman J; Masschaele D; Peelman F; Tavernier J
    J Cell Sci; 2013 Aug; 126(Pt 16):3770-81. PubMed ID: 23750007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. USP8 is a novel target for overcoming gefitinib resistance in lung cancer.
    Byun S; Lee SY; Lee J; Jeong CH; Farrand L; Lim S; Reddy K; Kim JY; Lee MH; Lee HJ; Bode AM; Won Lee K; Dong Z
    Clin Cancer Res; 2013 Jul; 19(14):3894-904. PubMed ID: 23748694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C8orf76 Modulates Ferroptosis in Liver Cancer via Transcriptionally Up-Regulating SLC7A11.
    Li D; Pan J; Zhang Y; Li Y; Jin S; Zhong C; Chen P; Ma J; Hu W; Fan X; Lin H
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma.
    Huang W; Chen K; Lu Y; Zhang D; Cheng Y; Li L; Huang W; He G; Liao H; Cai L; Tang Y; Zhao L; Pan M
    Neoplasia; 2021 Dec; 23(12):1227-1239. PubMed ID: 34768109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA binding protein DAZAP1 promotes HCC progression and regulates ferroptosis by interacting with SLC7A11 mRNA.
    Wang Q; Guo Y; Wang W; Liu B; Yang G; Xu Z; Li J; Liu Z
    Exp Cell Res; 2021 Feb; 399(1):112453. PubMed ID: 33358859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PNO1 inhibits autophagy-mediated ferroptosis by GSH metabolic reprogramming in hepatocellular carcinoma.
    Hu X; He Y; Han Z; Liu W; Liu D; Zhang X; Chen L; Qi L; Chen L; Luo Y; Li Q; Chen P; Wu Q; Zhu X; Guo H
    Cell Death Dis; 2022 Nov; 13(11):1010. PubMed ID: 36446769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation.
    Zhu Q; Zhou L; Yang Z; Lai M; Xie H; Wu L; Xing C; Zhang F; Zheng S
    Med Oncol; 2012 Jun; 29(2):985-93. PubMed ID: 21461968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.